In Vitro Comparison of Dodecafluoropentane (DDFP), Perfluorodecalin (PFD), and Perfluoroctylbromide (PFOB) in the Facilitation of Oxygen Exchange

被引:56
作者
Johnson, Jennifer L. H. [1 ]
Dolezal, Melissa C. [1 ]
Kerschen, Arthur [1 ]
Matsunaga, Terry O. [1 ]
Unger, Evan C. [1 ]
机构
[1] NuvOx Pharma LLC, Tucson, AZ 85719 USA
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY | 2009年 / 37卷 / 04期
关键词
TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; BLOOD SUBSTITUTES; PERFLUBRON EMULSION; STABILIZED BUBBLES; REPERFUSION INJURY; CONTRAST AGENT; PERFLUOROCARBONS; SOLUBILITY; PHARMACOKINETICS;
D O I
10.1080/10731190903043192
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 [微生物学]; 090105 [作物生产系统与生态工程];
摘要
The purpose is to prepare 2% w/v emulsions of dodecafluoropentane, perfluorodecalin, and perfluoroctylbromide and compare them for their ability to absorb oxygen. The oxygen uptake capability and volume expansion of each emulsion and the blank vehicle were evaluated in water at 21 degrees C and 37 degrees C. The average particle size of the dodecafluoropentane emulsion is 400 nm stored at room temperature for 6 months. In comparison to water treated with either the blank vehicle, the perfluorodecalin emulsion, or the perfluoroctylbromide emulsion, the dodecafluoropentane emulsion absorbs 3 times more oxygen at 21 degrees C and 7 times more oxygen at 37 degrees C. Furthermore, a significantly higher in vitro expansion (5 times) is observed with the dodecafluoropentane emulsion at 37 degrees C. As such, DDFP has been hypothesized to be a better oxygen carrier and delivery agent in vivo. This may be applicable to a variety of hypoxic medical conditions where oxygen delivery might be therapeutically beneficial.
引用
收藏
页码:156 / 162
页数:7
相关论文
共 30 条
[1]
OXYGEN-TRANSPORT TO TISSUE BY PERSISTENT BUBBLES - THEORY AND SIMULATIONS [J].
BURKARD, ME ;
VANLIEW, HD .
JOURNAL OF APPLIED PHYSIOLOGY, 1994, 77 (06) :2874-2878
[2]
Comparison of treatment modalities for hemorrhagic shock [J].
Cheung, Anthony T. W. ;
To, Patricia L. ;
Chan, Danielle M. ;
Ramanujam, Sahana ;
Barbosa, Michelle A. ;
Chen, Peter C. Y. ;
Driessen, Bernd ;
Jahr, Jonathan S. ;
Gunther, Robert A. .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2007, 35 (02) :173-190
[3]
Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography [J].
Correas, JM ;
Meuter, AR ;
Singlas, E ;
Kessler, DR ;
Worah, D ;
Quay, SC .
ULTRASOUND IN MEDICINE AND BIOLOGY, 2001, 27 (04) :565-570
[4]
Solubility of oxygen in substituted perfluorocarbons [J].
Dias, AMA ;
Gonçalves, CMB ;
Legido, JL ;
Coutinho, JAP ;
Marrucho, IM .
FLUID PHASE EQUILIBRIA, 2005, 238 (01) :7-12
[5]
Solubility of oxygen in liquid perfluorocarbons [J].
Dias, AMA ;
Freire, M ;
Coutinho, JAP ;
Marrucho, IM .
FLUID PHASE EQUILIBRIA, 2004, 222 :325-330
[6]
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke [J].
Fagan, SC ;
Morgenstern, LB ;
Petitta, A ;
Ward, RE ;
Tilley, BC ;
Marler, JR ;
Levine, SR ;
Broderick, JP ;
Kwiatkowski, TG ;
Frankel, M ;
Brott, TG ;
Walker, MD .
NEUROLOGY, 1998, 50 (04) :883-890
[7]
PHARMACOKINETICS AND SIDE-EFFECTS OF PERFLUOROCARBON-BASED BLOOD SUBSTITUTES [J].
FLAIM, SF .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1994, 22 (04) :1043-1054
[8]
ISCHEMIA - REPERFUSION INJURY [J].
GRACE, PA .
BRITISH JOURNAL OF SURGERY, 1994, 81 (05) :637-647
[9]
EFFECTS OF A PERFLUOROCARBON EMULSION FOR ENHANCED O-2 SOLUBILITY ON HEMODYNAMICS AND O-2 TRANSPORT IN DOGS [J].
JOHNSON, EC ;
ERICKSON, BK ;
PODOLSKY, A ;
BIRKS, EK ;
KEIPERT, PE ;
FAITHFULL, NS ;
WAGNER, PD .
JOURNAL OF APPLIED PHYSIOLOGY, 1995, 79 (05) :1777-1786
[10]
KERSCHEN A, 2007, UNIVERSAL COM LOGGER